These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 84095)

  • 1. [Endocrine ophthalmopathy in Graves disease during antithyroid drug therapy (author's transl)].
    Wuttke H; Schlieter D; Krück F
    Klin Wochenschr; 1979 Jan; 57(2):69-74. PubMed ID: 84095
    [No Abstract]   [Full Text] [Related]  

  • 2. [Stimulation of endogenous TSH secretion and endocrine orbitopathy].
    Wuttke H; Schlieter D
    Med Klin; 1980 Aug; 75(18):658-62. PubMed ID: 6158667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperthyroidism].
    Bürgi U; Maurer P
    Schweiz Rundsch Med Prax; 1994 Jan; 83(3):61-4. PubMed ID: 7507596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory tests for evaluating thyroid therapy.
    Kabadi UM
    Am Fam Physician; 1982 Sep; 26(3):183-8. PubMed ID: 6180620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of neonatal hyperthyroidism in infants born to mothers with Graves disease.
    Skuza KA; Sills IN; Stene M; Rapaport R
    J Pediatr; 1996 Feb; 128(2):264-8. PubMed ID: 8636826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of patients with thyrotoxicosis of childbearing age (author's transl)].
    Momotani N; Hamada N; Ban Y; Mimura T; Nishikawa Y
    Nihon Naibunpi Gakkai Zasshi; 1977 Oct; 53(10):1148-58. PubMed ID: 73481
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of effects of antithyroid drug treatment based mainly on the TRH test].
    Irie M; Enomoto K; Inoue K; Enomoto H; Nukii T
    Horumon To Rinsho; 1974 Feb; 22(2):249-50. PubMed ID: 4136015
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of thyrotoxicosis with lithium carbonate.
    Lazarus JH; Richards AR; Addison GM; Owen GM
    Lancet; 1974 Nov; 2(7890):1160-3. PubMed ID: 4139588
    [No Abstract]   [Full Text] [Related]  

  • 10. Differences between changes in serum thyrotropin-binding inhibitory antibodies and thyroid-stimulating antibodies in the course of antithyroid drug therapy for Graves' disease.
    Yamano Y; Takamatsu J; Sakane S; Hirai K; Kuma K; Ohsawa N
    Thyroid; 1999 Aug; 9(8):769-73. PubMed ID: 10482368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on the management of hyperthyroidism and hypothyroidism.
    Woeber KA
    Arch Fam Med; 2000 Aug; 9(8):743-7. PubMed ID: 10927715
    [No Abstract]   [Full Text] [Related]  

  • 12. Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug.
    McIver B; Rae P; Beckett G; Wilkinson E; Gold A; Toft A
    N Engl J Med; 1996 Jan; 334(4):220-4. PubMed ID: 8531998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early histological changes of the thyroid gland sway the prognosis of juvenile thyrotoxicosis treated with antithyroid therapy (author's transl)].
    Takata I; Saida K; Suzuki Y; Sato T
    Horumon To Rinsho; 1979 Sep; 27(9):938-42. PubMed ID: 93525
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical significance of elevated serum triiodothyronine to thyroxine ratios in patients with Graves' disease treated with antithyroid drugs].
    Takamatsu J
    Nihon Naibunpi Gakkai Zasshi; 1983 Mar; 59(3):295-303. PubMed ID: 6190686
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum thyroid hormones and TSH response to TRH during treatment of Graves' disease by carbimazole (author's transl)].
    Lorcy Y; Heim J; Auvray E; Allannic H
    Ann Endocrinol (Paris); 1979; 40(4):441-2. PubMed ID: 117739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in serum T3, T4 and TSH before and after the T3-suppression test in patients treated for Graves' disease (author's transl)].
    Tamai H; Suematsu H; Esaki M; Kurakawa N; Aoki H
    Nihon Naibunpi Gakkai Zasshi; 1977 Jan; 53(1):17-27. PubMed ID: 72007
    [No Abstract]   [Full Text] [Related]  

  • 17. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
    Buerklin EM; Schimmel M; Utiger RD
    J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug therapy of hyperthyroidism (author's transl)].
    Baumann G
    Ther Umsch; 1973 Oct; 30(10):734-9. PubMed ID: 4126863
    [No Abstract]   [Full Text] [Related]  

  • 19. Valuable predictive features of relapse of Graves' disease after antithyroid drug treatment.
    Liu X; Shi B; Li H
    Ann Endocrinol (Paris); 2015 Dec; 76(6):679-83. PubMed ID: 26514949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A patient-specific treatment model for Graves' hyperthyroidism.
    Pandiyan B; Merrill SJ; Di Bari F; Antonelli A; Benvenga S
    Theor Biol Med Model; 2018 Jan; 15(1):1. PubMed ID: 29310665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.